Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Farina is active.

Publication


Featured researches published by A. Farina.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Determination of optical purity by nonenantioselective LC using CD detection

Elena Bossù; Viviana Cotichini; Gianluca Gostoli; A. Farina

The use of a circular dichroism (CD) based HPLC detection system was recently described by some authors and proposed for a nonenantioselective HPLC enantiomeric purity determination. Indeed the system, measuring both CD and UV signals simultaneously, allows the evaluation of the g anisotropy factor. In order to experimentally support such an analytical procedure as an alternative to the enantioselective chromatographic method currently found in some pharmacopoeial monographs, we have studied its application to the analysis of dexchlorpheniramine maleate, an active substance which exhibits a poor CD signal in the 250-270 nm spectral region with a g value of the order of 10(-4). The results reported indicate that the suitability of the studied procedure for the enantiomeric purity determination is obtained only when the CD-detector reaches high stability; indeed a certain time lag is systematically necessary to obtain stable responses, i.e. adequate precision. The enantioselective HPLC procedure seems to be more precise for enantiomeric purity values < or = 2% than the CD based detection system; such a disadvantage might be counterbalanced by the use of non chiral stationary phases.


Journal of Pharmaceutical and Biomedical Analysis | 1999

Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach

A. Farina; Rita Porrà; Viviana Cotichini; A. Doldo

The stability of aqueous reconstituted ceftazidime injection vials containing ceftazidime pentahydrate blended with anhydrous sodium carbonate was investigated in different storage conditions (4 degrees C and 10 degrees C for 7 days in a refrigerator, 20 and 30 degrees C for 24 h) with validated HPLC and (micellar) CE methods. Stability indicating data were obtained for ceftazidime and two degradation products: pyridine and the delta2-ceftazidime isomer. Other degradation products were also identified (the complementarity of the two used experimental procedures was useful in such exercise) and characterized by their UV spectra and retention times. Stability data (7 days at 4 degrees C in a refrigerator and 18 h at room temperature) resulted in agreements with the manufacturers prescription and point out the need of a strict temperature control of the refrigerators compartment used to store the reconstituted solution.


Journal of Pharmaceutical and Biomedical Analysis | 1998

Analysis of ceftazidime and related compounds by micellar electrokinetic chromatography

Rita Porrà; A. Farina; Viviana Cotichini; Raffaele Lecce

A micellar electrokinetic chromatographic method for the separation and quantification of ceftazidime, its delta2-isomer and pyridine (two ceftazidime related impurities) was developed and validated. Optimised conditions were obtained using an electrolyte system consisting of 25 mM sodium tetraborate, at pH 9.2, and 75 mM sodium dodecylsulphate. A limit of detection of 0.2 microg ml(-1) and a limit of quantitation of 0.6 microg ml(-1) were estimated for pyridine and delta2-isomer: this means that levels of < 0.1% of pyridine and delta2-isomer in ceftazidime can be determined. Calibration curves for all analytes were linear over the studied ranges with correlation coefficients >0.999. Good reproducibility for migration times and corrected peak areas were achieved (RSD % 0.3 and 1.0, respectively). The results demonstrate that the method is reproducible, accurate and appropriate for ceftazidime assay in pharmaceutical samples.


Journal of Pharmaceutical and Biomedical Analysis | 2003

Determination of MPTP, a toxic impurity of pethidine

M.G. Quaglia; A. Farina; E. Donati; V Cotechini; Elena Bossù

Pethidine, predominantly a mu-receptor agonist, is a phenyl-piperidinic synthetic drug. It is used in the management of moderate to several pain. A possible hydrolytic degradation of an ester group can generate a very toxic compound, the N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) which contaminates the drug. Because of the toxicity of MPTP a suitable method for its determination must be selective and sensitive. Afterwards we propose simple methods to determine pethidine and MPTP by capillary electrophoresis (CE), MECK and RP-high performance liquid chromatography (HPLC) looking at the limit of detection obtained using these three techniques. CE was carried out using as running buffer ammonium acetate (pH 8.3). MECK was performed with a borate buffer (pH 8.3) containing sodium dodecylsulphate and trimethyl-beta-cyclodextrins. RP-HPLC was carried out on a RP18 stationary phase, using as mobile phase a mixture of phosphate buffer (pH 7) containing acetonitrile and 1% of diethylamine.


Journal of Pharmaceutical and Biomedical Analysis | 1998

Human α1-glycoprotein acid as chiral selector in the enantioseparation of midodrine and deglymidodrine racemates by HPLC

M.G. Quaglia; A. Farina; E. Bossù; Viviana Cotichini

Human alpha1-acid glycoprotein (alpha1-AGP) has been used as a chiral stationary phase (CSP) for the enantioseparation of midodrine and deglymidodrine racemates in the same HPLC run. The imobilized AGP resulted as the best chiral selector for the enantioresolution of two compounds. Due to the modification of alpha1-AGP characters as a result of changing the composition of the mobile phase, an attempt study of the watery mobile phase (ionic strength and pH of the buffer, nature and concentration of the organic modifier) allowed for an increase in the enantioselectivity of the chromatographic system and an optimization of the resolution base-line of both enantiomeric pairs.


Journal of Pharmaceutical and Biomedical Analysis | 1997

The indirect UV detection in the analysis of ursodeoxycholic acid and related compounds by HPCE

M.G. Quaglia; A. Farina; Elena Bossù; C. Dell'Aquila; A. Doldo

A high-performance capillary zone electrophoretic (HPCE) assay has been developed for the determination of ursodeoxycholic acid (UDCA) and its usual impurities. Considering the low molecular absorptivity of UDCA and its related compounds indirect UV detection was used. The electrophoretic capillary was filled with a background electrolyte (BGE) containing an UV absorbing ion: benzoic acid (BA) or 5,5-diethylbarbituric acid (DBA). To enhance the selectivity of the assay diimethyl-beta-cyclodextrines (D-beta-CDs) or trimethyl-beta-cyclodextrines (T-beta-CDs) have been added to the running buffer together with methylcellulose or urea. All considered impurities were well resolved with two buffers studied, with the exception of methylursodehoxycholate, a neutral compound.


Journal of Pharmaceutical and Biomedical Analysis | 1995

Analysis of non-benzodiazepinic anxiolytic agents by capillary zone electrophoresis

M.G. Quaglia; A. Farina; E. Bossù; C. Dell'Aquila

A simple capillary electrophoretic method was developed for the analysis of a new generation of serotonergic anxiolytics and their related substances: zalospirone, gepirone, ipsapirone and buspirone. All compounds run in a Tris/phosphate buffer at pH 3 as cations and the experimental conditions allowed good resolution of four drugs and their principal impurities. The analyses were made using two different kinds of capillary. The suitability of CZE and HPLC methods for the analysis of these non-benzodiazepinic anxiolytic agents and their impurities was compared.


Journal of Pharmaceutical and Biomedical Analysis | 1993

Analysis of ticlopidine and related impurities by capillary electrophoresis

M.G. Quaglia; A. Farina; E. Bossù; F. Romolo

Capillary electrophoresis has been used to analyse ticlopidine and its main impurities in bulk material. The minimum detectable amount of impurities was determined and the electrophoretic conditions used were discussed. The proposed method is also suitable to analyse the drug in plasma.


Journal of Chromatography A | 1994

Chromatographic resolution and pharmacological investigation of ICI 118551, a new β2-blocker

M.G. Quaglia; Nicoletta Desideri; E. Bossù; A. Farina; L.A. Morrone

Abstract ICI 118551, a highly selective β 2 -blocking compound, and its threo isomer, one of the possible impurities of drug, were resolved by high-performance liquid chromatography on a chiral stationary phase. The enantiomers of ICI 118551 were separately collected and the β 2 -blocking activity of each isomer was tested on the guinea pig trachea.


Journal of Pharmaceutical and Biomedical Analysis | 1992

Analysis of new serotonergic anxiolytics by liquid chromatography

A. Farina; A. Doldo; M.G. Quaglia

A simple isocratic procedure was developed for the analysis of new serotonergic anxiolytics and the related compounds in bulk materials, pharmaceutical formulations and in biological samples. The system may be applied for the assay of other serotonergic anxiolytics of related structure such as buspirone. The liquid chromatographic assay utilizes a reversed-phase C18 column, a mobile phase consisting of a mixture (55:45, v/v) of (A) buffer potassium dihydrogen phosphate (0.05 M) containing sodium lauryl sulphate (0.005 M) and (B) acetonitrile. A fluorescence detection is used with lambda ex 237 nm; lambda cm 374 nm. The accuracy, precision and sensitivity of the proposed method are established. Standard curves are linear with respect to concentration in the range 0.05-7.5 micrograms ml-1. The method also allows the separation and identification of related compounds at concentrations below 0.01%.

Collaboration


Dive into the A. Farina's collaboration.

Top Co-Authors

Avatar

M.G. Quaglia

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Elena Bossù

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

E. Bossù

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

A. Doldo

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Viviana Cotichini

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Gianluca Gostoli

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Raffaele Lecce

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Annalisa Montinaro

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

C. Dell'Aquila

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

E. Donati

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge